Zilucoplan for Severe gMG Exacerbations

Clinical trial NCT07215949 · RECRUITING

Trial details

NCT number: NCT07215949
Sponsor: Miriam Freimer
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Myasthenia Gravis (gMG)

Start date: 2026-01-20
Primary completion: 2027-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.